Introduction
The patient is a fifty-year-old female with a past medical history notable for congestive heart failure, hypertension and hyperlipidemia. In December of 2011, she sustained a myocardial infarction and received a 2.25 × 26 mm Integrity (0.0889 mm) Bare Metal Stent (BMS) to the mid Left Anterior Descending (LAD) artery for a 90% stenotic lesion. In October of 2013, she presented with chest pain (CP) and underwent coronary angiography. It revealed in-stent restenosis along the entire length of the previously placed BMS. She was re-stented with a 2.25 × 32 mm Promus Element (0.081 mm) drug eluting stent (DES) and was discharged on aspirin and prasugrel along with her other cardiac medications. Ten days later, she presented to the emergency department (ED) again with acute CP in the setting of non-compliance with prasugrel for the previous 3 -4 days. In the ED she had a ventricular fibrillatory arrest and was resuscitated. Electrocardiography revealed ST elevation in the anterior-septal leads consistent with anterior wall myocardial infarction (MI) (Figure 1) . She was brought emergently to the cardiac catheterization lab where angiography confirmed a total occlusion at the site of the LAD stent (Figure 2) . After aspiration thrombectomy, an intravascular ultrasound study (IVUS) revealed underdeployment of the LAD stent (Figure 3 ) with residual disease proximal and distal to the stent. She underwent balloon dilatation of the underdeployed stent. A new 2.25 × 26 mm Resolute (0.0889 mm) DES was deployed distally at 8 atmospheres (atm) in an overlapping fashion with the overlapping area post dilated at 12 atmospheres. A Resolute 3.0 × 18 mm DES was deployed proximally overlapping the proximal Integrity BMS and the Promus Element DES stent. Repeat angiography revealed underexpansion of the distal stent, and the patient underwent another high-pressure balloon inflation of the distal stent with the 3.0 mm stent balloon. Follow up angiography revealed two coronary perforations at the overlap region of the previously placed Integrity, Promus, and proximal aspect of the newly deployed distal Resolute stent with extravasation of contrast into the LV cavity (Figure 4, Figure 5 ). No extravasation of contrast was noted in the pericardial space. A diagnosis of a Type 4 (also known as Cavity Spilling) Ellis coronary artery perforation (CAP) was made. Immediately the 3.0 mm stent balloon was deployed to impede any free leak of blood ( Figure 6 ). Emergent bedside echocardiography did not reveal any pericardial effusion. With the intracoronary balloon in place, contralateral access was obtained and another coronary guide was used to simultaneously engage the left coronary artery. A second 0.014" coronary wire was placed distal to the perforations, with the continuous balloon tamponade interrupted only transiently to allow wire passage. A 3.0 × 19 mm Jomed covered stent was rapidly deployed in a "quick replacement" manner. The two perforations were completely sealed, with resultant TIMI grade 3 flow confirmed on angiography ( Figure 7) . Her remaining hospital course was uneventful and she was discharged on the 10 th day of her hospitalization. She has been asymptomatic since discharge. 
Discussion
Coronary artery perforation (CAP) during angioplasty is rare with an estimated incidence of 0.19% to 0.59% [1] . Review of the literature cites a number of predisposing risk factors including advanced age, female gender, hypertension, hyperlipidemia, diabetes, chronic renal failure, history of prior coronary artery bypass graft (CABG), heavy coronary artery calcification, chronic total occlusion, tortuous vessels, target lesions in the circumflex and right coronary arteries, long target lesions (>10 mm), eccentric lesions, and small vessel size amongst others [2] . During percutaneous coronary intervention (PCI), coronary artery perforation may occur as a consequence of hydrophilic or extra stiff guide wire advancement, excessive over-dilation of a stent under high pressure or use of an oversized stent with high-pressure balloons, use of an atheroablative device, laser angioplasty, or IVUS catheter use for PCI optimization [1] .
According to Ellis et al., the diagnosis and classification of coronary artery perforation is based on the angiographic appearance of the perforation [3] . If the perforation is limited to the vessel wall (i.e., produces an intramural crater without extravasation on the angiogram) it is diagnosed as an Ellis Type 1 CAP, and has a benign prognosis [2] . Ellis Type 2 CAP has limited extravasation with pericardial or myocardial blushing on angiography. The perforation size is generally less than 1 mm in diameter, and because there is extravasation into the pericardial space, Ellis Type 2 perforations have the potential to progress to tamponade [1] . Ellis Type 3 perforations result in prominent streaming of contrast into the pericardial space and the exit hole is generally greater than 1 mm [2] . Type 3 lesions are associated with hemodynamic instability, and nearly 50% of the cases lead to cardiac tamponade requiring pericardial drainage [1] . Some of the Type 3 CAP were noted to be spilling into an anatomic cavity, and thus these perforation types were referred to as "Cavity Spilling" by Ellis et al. Some authors have listed these Cavity Spilling perforations as Ellis Type 4 [4] . In Type 4 or Cavity Spilling CAP, the contrast flows into a cardiac chamber such as the LV or a coronary sinus rather than into the pericardial space or myocardium [2] . Among the various types of CAP, Ellis Type 1 lesions have the most benign prognosis, while Ellis Type 3 lesions have the potential for the worst prognosis. Ellis Type 4/Cavity Spilling types of perforations are the least frequent; no studies have looked at its exact specific incidence rate or overall prognosis. A recent report by Meguro et al., analyzed 3469 PCIs, and found 30 CAP (overall incidence of 0.86%), and of these 30 cases, 17 cases were of Type I CAP, two cases of type II CAP, and 11 type III CAP cases. However a distinction between Type 3 perforation and Cavity Spilling perforation was not made. In the study, most cases of Type 1 CAP were causes by wires/balloons, while Type 3 CAP were mostly due to stents. Most cases of stent CAP were successfully managed with prolonged balloon inflations with one third requiring CABG [5] . Another study by Aykan et al., analyzed 12,784 PCIs retrospectively, and 25 CAP were found (overall incidence of 0.02%), and of these 25 cases, 14 patients had ACS (6 STEMI, 8 NSTEMI). Type 1 CAP was found in 8 of 25 patients (32%), Type 2 in 6 (24%) patients, and Type 3 in 11 (44%) patients. Again a distinction between Type 3 and Cavity Spilling perforation was not made. Emergent CABG was required in 2 patients with Type 3 CAP, and there were no in-hospital mortality in the 25 patients. The study concludes that outcomes or near-term prognosis of CAP in patients with ACS were similar to patients with stable coronary disease [6] . However, to our knowledge, there have been no recent studies that have looked at iatrogenic CAP long-term prognosis.
Coronary artery perforations are generally managed with covered stents and reversal of anticoagulation with success rates reported in the literature of greater than 90% [7] . Ellis Type 1 and 2 perforations can be treated with prolonged balloon inflation, which is best done with a perfusion balloon catheter [1] . In general, covered stents are ideal for proximal or mid-segment perforations. BMS with narrow struts can be used for distal lesions [7] . Coronary artery perforations can also be treated with various embolization materials such as metal coils, collagen, glue, thrombogenic particles such as polyvinyl alcohol, gelfoam, thrombin, or N-butyl cyanoacrylate glue. Surgery, given the high success rate of PCI is often considered as a last resort. Surgical options include operative repair with ligation or suturing of the perforated vessel, placement of a bypass graft to the distal vessel, pericardial patch or Teflon felt wrapping repair [1] .
When "cavity spilling" types of perforations or coronary cameral fistulas are encountered the treatment options are unclear. Since the perforation is not spilling into the pericardial space, it is considered an artery-artery fistula. Questions arise whether it is necessary to intervene emergently. Considering that covered stents have high occlusion rates, BMS stents have high restenosis rates and embolization results in downstream infarct, the best possible treatment choice is difficult. Previous studies in coronary cameral fistulas have revealed that traumatic coronary artery-cameral fistulas (TCAF) resulting from penetrating cardiac trauma are highly lethal, and require early surgical intervention [8] . In comparison, iatrogenic traumatic acquired coronary artery cameral fistulas (CCF) (such as those from stent placement in a chronic total occluded vessel) and spontaneously acquired CCF (which develop post-MI) have low flow, and can be treated with supportive medical management [9] . There have been case reports of spontaneous closure of cavity spilling perforation after PCI [8] [9] . Therefore it seems reasonable to treat large and moderate sized coronary perforations into the left ventricle while reserving a conservative strategy for smaller ones. There are no standard management recommendations, and therapy should be tailored according to the clinical context and patient stability.
The IVUS study in the current case revealed an under-deployed stent, which is a common and underappreciated occurrence. In such instances, not many options exist but to use a high-pressure balloon to dilate the stent. One rare complication of high-pressure stent strut dilation is CAP with incidence reported as 0.1% to 3.0% of PCI procedures. Stenting causes vessel wall injury, the extent of which is determined by the number of stent struts involving a vessel lumen, and the degree of stent strut dilation (i.e., hence the anatomic depth at which the stent struts penetrate the vessel wall). Balloon expansion advances the strut through the internal elastic lamina, then the media, external elastic lamina, and finally adventia [10] . In humans stent struts account only for 32% of direct medial injury as most struts are in contact with atheromatous plaque and not the media [11] .
The current era stent struts are relatively thin with the diameter varying between 0.0032 -0.0035 inches (with Resolute DES at 0.0889 mm (0.0035"), PROMUS Element DES at 0.081 mm (0.0032"), Integrity BMS at 0.0889 mm (0.0035")). In our patient, the combined thickness of three overlapping stents is 0.2659 mm (0.0889, 0.0889, 0.0881) or greater than a quarter of a one millimeter. When deployed under high pressure one could readily hypothesize a predilection to stent perforation. Post stent dilation of this triple "stent sandwich" may have resulted in expansion of the overlapping stent struts against acutely inflamed myocardium causing a cavity spilling type of perforation.
With the CAP draining to the LV alone, there was no need for emergent pericardiocentesis, thus allowing for execution of a well thought out management plan. We chose to deploy a covered stent over the perforation with interim balloon tamponading. Deployment of the single stent successfully sealed both perforation sites. The patient remained stable and did not complain of chest pain throughout the procedure.
Follow-Up
The patient did well post procedure, and was discharged on dual antiplatelet therapy. She is continuing to do well. This, to our knowledge, is the first reported case of an acquired coronary cameral fistula due to post stent dilatation.
This case is thought provoking as it outlines current options for CAP treatment, discusses some of the challenges in its management, and additionally highlighting the dangers of high pressure balloon dilation when there are multiple overlapping stents. There are no standard management guidelines in such instances and therapy must be customized. Severe complications associated with CAP reinforce the necessity for interventionists to take measures to minimize risks. Awareness of risk factors with careful guidewire and balloon size selection, and avoidance of stent overexpansion is vital to CAP prevention.
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